Medicare Enrolled

Dr. Ryan Kahl, D.O.

Internal Medicine · Sherman, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
425 N HIGHLAND AVE STE 130, Sherman, TX 75092
9038929179
In practice since 2015 (10 years)
NPI: 1275911109 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kahl from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kahl? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kahl

Dr. Ryan Kahl is an internal medicine specialist in Sherman, TX, with 10 years of NPI registration. Based on federal Medicare data, Dr. Kahl performed 712 Medicare services across 615 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kahl received a total of $7,048 from 44 pharmaceutical and/or device companies across 218 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kahl is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 47% volume in TX $7,048 industry payments

Medicare Practice Summary

Medicare Utilization ↗
712
Medicare services
Top 47% in TX for internal medicine
615
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 175 $89 $217
Removal of polyps or growths of large bowel using an endoscope with mechanical snare 110 $200 $1,067
Upper GI endoscopy with biopsy 94 $65 $680
New patient office visit (45-59 min) 74 $112 $333
Office visit, established patient (20-29 min) 64 $67 $148
Initial hospital admission, high complexity 39 $131 $411
Initial hospital admission, moderate complexity 38 $100 $278
Hospital follow-up visit, moderate complexity 36 $61 $146
Colonoscopy with biopsy 35 $92 $847
Colorectal cancer screening; colonoscopy on individual at high risk 17 $174 $778
New patient office visit (30-44 min) 16 $70 $219
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 14 $149 $781
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,048
Total received (2018-2024)
Avg $1,007/year across 7 years
Top 12% in TX for internal medicine
44
Companies
218
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,931 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$117 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,642
2023
$1,109
2022
$1,126
2021
$567
2020
$442
2019
$1,138
2018
$1,025

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,503
Gilead Sciences, Inc.
$712
AbbVie, Inc.
$618
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$381
Janssen Biotech, Inc.
$335
Takeda Pharmaceuticals U.S.A., Inc.
$331
Janssen Scientific Affairs, LLC
$317
Regeneron Healthcare Solutions, Inc.
$289
AbbVie Inc.
$237
Ambu Inc.
$172
Intercept Pharmaceuticals, Inc.
$163
Ardelyx, Inc.
$154
Medtronic, Inc.
$148
QOL Medical, LLC
$147
AIMMUNE THERAPEUTICS, INC.
$138
Boston Scientific Corporation
$136
Dova Pharmaceuticals
$122
Celgene Corporation
$119
Synergy Pharmaceuticals Inc
$116
E.R. Squibb & Sons, L.L.C.
$115
VIVUS LLC
$91
Axonics, Inc.
$85
INTERCEPT PHARMACEUTICALS, INC.
$76
Merck Sharp & Dohme LLC
$58
GENZYME CORPORATION
$50
PFIZER INC.
$44
Phathom Pharmaceuticals, Inc.
$39
Ironwood Pharmaceuticals, Inc
$38
Olympus America Inc.
$36
Alnylam Pharmaceuticals Inc.
$28
Micro-tech Endoscopy USA, Inc.
$26
Nestle HealthCare Nutrition Inc.
$26
Lilly USA, LLC
$23
Evoke Pharma, Inc.
$21
IRONWOOD PHARMACEUTICALS, INC
$19
Madrigal Pharmaceuticals
$19
EVOKE PHARMA, INC.
$17
Enterra Medical, Inc.
$16
Myriad Genetic Laboratories, Inc.
$16
NESTLE HEALTHCARE NUTRITION INC.
$14
RedHill Biopharma Inc.
$14
Horizon Pharma plc
$13
Novartis Pharmaceuticals Corporation
$13
Cook Medical LLC
$11
Top 3 companies account for 40.2% of total payments
Associated products mentioned in payments ›
Abraxane · Axonics · CREON · Compliance EndoKit · Cook Medical Biliary · DIFICID · DUPIXENT · Doptelet · ENTYVIO · EOHILIA · EVIS EXERA · Epclusa · GATTEX · GI GENIUS · GI Genius · GIMOTI · GIVLAARI · HUMIRA · Humira · IBSRELA · INFLECTRA · KRYSTEXXA · LINZESS · Linzess · Livdelzi · MAVYRET · MOTEGRITY · MYRISK · Mavyret · OCALIVA · OMVOH · Otezla · Pomalyst · QSYMIA · REMICADE · RESMETIROM · RINVOQ · RYDAPT · Rapide Balloons · SKYRIZI · STELARA · SUCRAID · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · VIBERZI · VOQUEZNA · Vemlidy · WATCHMAN · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $990 per 100 Medicare services performed
Looking for an internal medicine specialist in Sherman?
Compare internal medicine physicians in the Sherman area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
43
Per 100K population
30.7
County median income
$70,455
Nearest hospital
WILSON N JONES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kahl is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kahl experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kahl performed 175 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kahl receive payments from pharmaceutical companies?
Yes. Dr. Kahl received a total of $7,048 from 44 companies across 218 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kahl's costs compare to other internal medicine physicians in Sherman?
Dr. Kahl's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kahl) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →